Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson's disease patient while actively treated with deep brain stimulation [1]

Movement Disorders

Volumn 22, Issue 1, 2007, Pages 148-

  Factor, Stewart A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; CLONAZEPAM; DANTROLENE; DOPAMINE; ENTACAPONE; LEVODOPA; NORADRENALIN; PERGOLIDE; QUETIAPINE; SERTRALINE;

ADULT; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REGIMEN; EPILEPTIC STATE; FATALITY; HUMAN; HYPOTENSION; INTENSIVE CARE; LETTER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; PARKINSONISM HYPERPYREXIA SYNDROME; PRIORITY JOURNAL; SHOCK;

ADULT; DEEP BRAIN STIMULATION; HUMANS; MALE; MALIGNANT HYPERTHERMIA; PARKINSON DISEASE; PARKINSONIAN DISORDERS;

EID: 33847757889     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21172     Document Type: Letter

References (5)

1. Vingerhoets FJG, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
2. Kleiner-Fisman G, Saint-Cyr JA, Miyasaki J, Lozano A, Lang AE. Subthalamic DBS replaces levodopa in Parkinson's disease. Neurology 2002;59:1293-1294.
3. Gordon PH, Frucht SJ. Neuroleptic malignant syndrome in advanced Parkinson's disease. Mov Disord 2001;16:960-961.
4. Linazasoro G, Van Blercom N, Castro A, Dapena MD. Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson's disease. Neurology 2004;63:589-590.
5. Factor SA, Santiago A. Parkinsonism-hyperpyrexia syndrome in Parkinson's disease. In: Frucht S, Fahn S, editors. Movement Disorder Emergencies: Diagnosis and Treatment. New York: Humana Press; 2005. p 29-40.